New Portable Device Accurately Measures Fat Burning Through Breath Analysis
Researchers at ETH Zurich have introduced a portable device that can detect when the body begins to burn fat during dieting or exercise by measuring acetone levels in exhaled breath. This innovative device operates with a level of accuracy comparable to that of a mass spectrometer, which is the standard for such measurements. Acetone, a by-product of fat metabolism, is exhaled when the body utilizes fat instead of carbohydrates for energy.
The design of the device is reminiscent of alcohol breathalyzers used by law enforcement, making it user-friendly and accessible for non-experts through a smartphone application. This advancement means individuals can track their fat metabolism independently, without the need for blood tests or professional assistance.
According to Andreas Güntner, a professor of molecular sensing at ETH Zurich, the ability to self-monitor metabolic responses is crucial since dietary needs can vary significantly among individuals. He emphasized the importance of developing methods that yield reliable results akin to blood glucose monitoring for diabetics.
The measuring device was created in collaboration with the ETH spin-off Alivion and underwent rigorous testing with the University Hospital Zurich. In a validation study involving 12 adults, researchers compared 312 breath readings from the new device against blood test results and high-precision mass spectrometer measurements across various metabolic scenarios, including different diets and levels of physical activity. The results indicated that the device's readings were nearly identical to those obtained from laboratory methods, demonstrating its reliability over several months.
The device utilizes advanced sensor technology that has been in development for over a decade at ETH Zurich. It was first introduced in 2017, when researchers showcased its ability to detect a single acetone molecule among a hundred million other molecules. Current acetone breathalyzers, they noted, often lack reproducibility and can only detect significant metabolic changes, as they are sensitive to other components in exhaled air.
To enhance accuracy, the researchers implemented a filter that blocks interfering molecules and a smartphone app that guides users in real time during the exhalation process. The device measures the volume of exhaled air and captures samples from deep within the lungs after a specific duration, ensuring consistent readings.
The successful validation of this hand-held device marks a significant milestone, as it can accurately detect subtle differences in fat metabolism. Future studies aim to explore its potential in personalizing therapies for metabolic disorders, including its application in helping children with epilepsy monitor their ketogenic diets in collaboration with the University Children’s Hospital Zurich. Additionally, the device may assist in optimizing medical diets and GLP-1 therapies associated with weight loss.
The device, branded as Nutrion by Alivion AG, is currently being utilized in international research studies and medical facilities. To expand its applications, Alivion is seeking partnerships with industry stakeholders and strategic investors. Güntner highlighted that this development exemplifies how fundamental research can lead to practical solutions that benefit society.
The findings from this research are published in the journal Device, with financial support from Innosuisse, the Vontobel Foundation, and the Accentus Foundation.




